Effect of Uric Acid-Lowering Agents on Patients With Heart Failure: A Systematic Review and Meta-Analysis of Randomised Controlled Trials

Background: Elevated serum uric acid (SUA) level is considered an independent predictor of all-cause mortality and the combined endpoint of death or readmission in cardiovascular disease patients. However, the causal relationship between uric acid-lowering therapies (ULTs) and heart failure is still...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Hongxuan, Liu, Yunqing, Meng, Lingbing, Wang, Li, Liu, Deping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144321/
https://www.ncbi.nlm.nih.gov/pubmed/34046437
http://dx.doi.org/10.3389/fcvm.2021.639392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144321/
https://www.ncbi.nlm.nih.gov/pubmed/34046437
http://dx.doi.org/10.3389/fcvm.2021.639392

Ejemplares similares